[The treatment of ambulant hypertensive patients with a combination of a saluretic and a beta-receptor blocker (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000553:Ambulatory Care; D001581:Benzothiadiazines / Q000627:therapeutic use*; D002046:Bupranolol / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D011412:Propanolamines; C025276:bemetizide, bupranolol, triamterene drug combination; D002046:Bupranolol; D014223:Triamterene
Behandlung ambulanter Hypertoniker mit einer Saluretika-Beta-Rezeptorenblocker- Kombination.